As Omicron infections zoom, so does Dolo's market share

Even as the country faces an alarming increase in Covid-19 infections primarily due to the Omicron variant, Dolo 650 has seen high demand as those with fever and body ache scramble to keep the pain away.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/33yqAeF
via IFTTT